BCIwiki — Brain-computer interface news, research and industry database

Neurosom announced it has been granted a patent for a method that combines Bayesian statistical modeling with personalized EEG data and brain atlas models to achieve "super-resolution" in locating the origins of brain electrical activity, potentially improving the guidance of transcranial electrical stimulation (TES). The patent, titled "Method for Bayesian Super-Resolution of Electroencephalographic Source Analysis and Transcranial Electrical Stimulation" (US Pat. No. 12,663,866), was announced on July 9, 2026.

A preprint shows that functional ultrasound imaging (fUSI), read through an acoustically transparent cranial-window implant, reliably resolved multi-body-part and single-digit movement encoding in one participant's primary sensorimotor cortex, with maps consistent with classical somatotopy and single-trial decoding supported across sessions; analysis of key decoding voxels suggested different Brodmann areas encode single-digit movement differently. The researchers argue fUSI can map motor representations at submillimeter resolution, filling a key gap in humans between invasive electrophysiology and non-invasive blood-flow imaging; the work has not been peer reviewed.

Sixteen departments in China's Shandong province, led by the Health Commission, issued the Work Plan for Accelerating Clinical Translation and Application Innovation of Brain-Computer Interfaces, document number Lu Wei Yi Zi [2026] No. 13, dated July 7, 2026 and released on July 8. It is the only provincial BCI document led by a health authority and Shandong's second after the science department's industry plan. The plan advances a positioning it summarises as validated in Shandong, applied globally, working through an alliance, scenarios, policy and industry follow-through. Targets rise in four steps: an operating clinical research alliance in 2026; about 20 core technology breakthroughs and 30 technology SMEs by 2027; at least 30 alliance members, more than 20 foreign and domestic teams setting up validation bases, more than 30 multicentre projects and a 2 billion yuan industry by 2028; and a national validation cluster by 2030.

NIRx Medical Technologies and Artinis Medical Systems, the Dutch fNIRS pioneer, have formed a strategic partnership backed by healthcare investor Gilde Healthcare to speed innovation and broader adoption of functional near-infrared spectroscopy (fNIRS) brain imaging. Both companies keep their own brands and operating locations while combining R&D and commercial scale, and leadership is unchanged, with Dr. Patrick Britz remaining chief executive of NIRx and Dr. Willy Colier chief executive of Artinis.

A preprint uses the Adaptive Thinking Mapper (ATM) model to empirically assess how EEG preprocessing strategies — a baseline MVNN-only pipeline versus a full cleaning pipeline integrating ICA and notch filtering — affect channel-attention representations in visual EEG decoding, using cross-generalization, noise-robustness, and spectro-temporal ablation analyses and examining the structural correspondence between data-driven attention weights and neurophysiological reference networks (GPDC, PDC, DTF). The researchers report the full pipeline suppressed non-neural artifacts such as frontal noise while maintaining comparable decoding accuracy and baseline robustness, and the learned attention spatial organization stayed stable across pipelines. The work has not been peer reviewed.